Kate Georgen, Principal

  • Market and Product Revenue Forecasting for a variety of diagnostic products for potential licensing deals
  • Market support for several major and many minor potential acquisitions
  • Market and Product Revenue Forecasting for several White Space Opportunities
  • Analysis in support of Patent Estate challenges
  • Competitive analysis supporting FTC approval of Acquisitions and Divestitures   

Broad based Market Analytical skills honed over 25 years of supporting more than 100 potential technology deals for Ortho Clinical Diagnostics, a Johnson & Johnson company. Representative projects included:

In addition, Kate served as Market Development Executive for an in-house start-up Oncology Diagnostic entity, as well as Product Manager for Hepatitis Screening products.

Recent Kate Georgen Services Consulting projects include:

  • Multi-market analysis in support of a novel drugs of abuse diagnostic system
  • Assessing demand for testing abuse deterrent opioid Rx formulations
  • Investigating the future of ultra-rapid DNA testing technology

Kate holds an MBA degree from the Wharton School of Business and a BS Biology degree from the University of Notre Dame.